Glycocalicin in the diagnosis and management of immune thrombocytopenia

European Journal of Haematology

Volumn 61, Issue 2, 1998, Pages 77-83

  Steffan, A ^b   Predella, P ^b   Cordiano, I ^a   Girolami, A ^a   De Marco, L ^b   Fabris, F ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

Glycocalicin; Immune thrombocytopenia; Platelet

Indexed keywords

GLYCOCALICIN;

ADULT; ARTICLE; BONE MARROW APLASIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; FEMALE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THROMBOCYTOPENIA;

EID: 0031830969     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1998.tb01065.x     Document Type: Article

References (17)

1. GARG SK, AMOROSI EL, KARPATKIN S. The use of the megathrombocyte as an index of megakaryocytic number. N Engl J Med 1971: 284: 11-17.
2. PAULUS JM. Platelet size in man. Blood 1975: 46: 321-336.
3. HUNT FA. A rapid method for assessing megathrombocytes: its application to thrombocytic and acquired thrombocytopenic states. Pathology 1976: 8: 47-55.
4. 111 labeled platelets: studies on preparation and evaluation of in vitro and in vivo functions. Thromb Res 1976: 9: 345-357.
5. COLLER BS, KALOMIRIS E, STEINBERG M, SCUDDER LE. Evidence that glycocalicin circulates in normal plasma. J Clin Invest 1984: 73: 794-799.
6. TRUGLIA JA, STRACHER A. Purification and characterization of a calcium-dependent sulphydryl protease from human platelet. Biochem Biophys Res Commun 1981: 100: 814-822.
7. STEINBERG MH, KELTON JG, COLLER BS. Plasma glycocalicin. An aid in the classification of thrombocytopenic disorders. N Engl J Med 1987: 317: 1037-1042.
8. KUNISHIMA S, HAYASHI K, KOBAYASHI S, NOAL T, OHNO R. New enzyme-linked immuno-adsorbent assay for glycocalicin in plasma. Clin Chem 1991: 37: 169-172.
9. BEER JH, BUCHI L, STEINER B. Glycocalicin: a new assay the normal plasma levels and its potential usefulness in selected diseases. Blood 1994: 83: 691-702.
10. KELTON J, GIBBONS S. Autoimmune platelet destruction: idiopathic thrombocytopenic purpura. Semin Thromb Hemost 1982: 8: 83-104.
11. FABRIS F, ZANATTA N, CASONATO A, RANDI ML, LUZZATTO G, GIROLAMI A. Response to splenectomy in idiopathic thrombocytopenic purpura: prognostic value of the clinical and laboratory evaluation. Acta Haemat 1989: 81: 28-33.
12. HANDA M, TITANI K, HOLLAND LZ, ROBERTS JR, RUGGERI ZM. The von Willebrand factor-binding domain of platelet membrane glycoprotein Ib. J Biol Chem 1986: 261: 12579-12585.
13. MURATA M, WARE J, RUGGERI ZM. Site-directed mutagenesis of a soluble recombinant fragment of platelet glycoprotein Ib-alfa demonstrating negatively charged residues involved in von Willebrand factor binding. J Biol Chem 1991: 286: 15474-15480.
14. VICENTE V, KOSTEL PJ, RUGGERI ZM. Isolation and functional characterization of the von Willebrand factor-binding domain located between residues His1-Arg293 of the alpha-chain of glycoprotein Ib. J Biol Chem 1988: 263: 18473-18479.
15. ORDINAS A, MARAGALL S, CASTILLO R, NURDEN AT. A glycoprotein I defect in the platelets of three patients with severe cirrhosis of the liver. Thromb Res 1978: 13: 297-302.
16. SLOAND EM, SLOAND JA, PRODOUZ K, et al. Reduction of platelet glycoprotein Ib in uremia. Br J Haematol 1991: 77: 375-381.
17. KUNISHIMA S, KOBAYASHI S, NAOE T. Increased but highly dispersed levels of plasma glycocalicin in patients with disseminated intravascular coagulation. Eur J Haematol 1996: 56: 173-177.